Gushengtang Holdings Limited provided earnings guidance for the Six Months Ended June 30, 2023. For the period, the company expects Group will record (a) a net profit for 1H2023 in the range of approximately RMB 90 million to RMB 95 million as compared with the restated net profit for the six months ended June 30, 2022 ("1H2022") of approximately RMB 53.6 million, representing an increase by approximately 68% to 77%; and (b) an increase in adjusted net profit for 1H2023 by approximately 55% to 65% as compared with that for 1H2022. Based on the information currently available to the Board, the Board believes that: the increase in net profit was primarily due to the business expansion including (i) the increase in the number of physicians in the online healthcare platforms and (ii) the growth in the number and geographic coverage of the offline medical institutions; and the increase in adjusted net profit (as defined by the Group as the net profit eliminating the effect of equity-settled share-based payment in relation to the share options granted under the pre-IPO share option plan approved and adopted by the Company on March 31, 2021 (the "Adjusted Item")) was mainly due to the effect of the business expansion of the online healthcare platforms and the increase in revenue generated by the new and existing offline medical institutions.